Roundup: Oxford Drug Design raises £2.2M to develop AI programme, Rune Labs launch Portuguese subsidiary to enhance diabetes care, and extra briefs

Oxford Drug Design raises £2.2M to develop AI-based drug discovery programme

Biotechnology agency Oxford Drug Design Restricted (ODD) has raised £2.2M in funding from current buyers ACF Traders, o2h Ventures, Meltwind Advisory, a number of returning angels and new buyers and the US-based R42 Group.

The Oxford College spinout has created a man-made intelligence (AI) AI proprietary platform for drug discovery, targeted on unmet therapeutic wants in oncology.

Alan D Roth, CEO, ODD, mentioned: “This newest funding will allow us to construct on and speed up our profitable computational design-led discovery focus. We’re excited to be enjoying a pivotal function within the innovation of oncological remedies main to higher outcomes for most cancers sufferers worldwide.”

Rune Labs launch Portuguese subsidiary to enhance diabetes care

Precision neurology software program and knowledge platform firm Rune Labs has introduced the creation of a staff of lead designers primarily based in Lisbon, Portugal.

The brand new staff shall be targeted on increasing options and workflows for Rune Labs’ StrivePD ecosystem for Parkinson’s care. The subsidiary may even be Rune’s first everlasting presence in Europe.

Will Newby, VP of product, Rune Labs, mentioned: “Rune Labs is targeted on enabling human-centred care to folks residing with Parkinson’s, and the Portugal staff of product designers will make sure that sufferers, clinicians, and researchers have a voice in our merchandise.”

Babylon GP at Hand opens two new clinics in London

Babylon GP at Hand has opened two new clinics in London that can present sufferers with face-to-face appointments alongside its digital-first built-in care.

The primary clinic in Dean Farrar Road, Victoria, opened final week and has been adopted by a clinic on Drummond Road, Euston.

Dr Matthew Noble, UK medical director, Babylon, mentioned: “In-person care is so essential alongside highly-accessible digital appointments and we’re actually excited to launch these two new clinics for our Babylon GP at Hand sufferers in London.”

CDP Enterprise Capital launches digital well being startup accelerator

CDP Enterprise Capital Sgr has introduced the launch of an accelerator for digital well being startups, with a concentrate on progressive options for respiratory illnesses, ophthalmology, ladies’s well being, uncommon illnesses and continual ache administration.

The VITA programme has been arrange along with Healthware Group and Danish accelerator Accelerace with complete belongings below administration of Є6.35 million.

Roberto Ascione, CEO and founder, Healthware Group, mentioned: “The VITA accelerator is testomony to Healthware’s dedication to contributing to the digital well being transformation, supporting the expansion and improvement of essentially the most promising startups.”

Functions are open to Italian startups and worldwide startups meaning to arrange registered workplaces in Italy, till 12 June.

Scientific trial finds blood check can establish 79% of early-stage bowel most cancers

A major care scientific trial in West Wales discovered {that a} blood check was capable of decide up 79% of early-stage bowel cancers and 100% of superior bowel cancers.

The Raman Spectrometry (RS) blood check was developed by Swansea College spin-out CanSense, with funding from Most cancers Analysis Wales and Well being and Care Analysis Wales.  

CanSense have additionally secured £1.2 million from the Nationwide Institute for Well being and Care Analysis (NIHR) to additional develop the blood check to make use of in scientific apply throughout Wales.  

Dr Cerys Jenkins, cofounder and director, CanSense, mentioned: “Having this check accessible on the triage stage would save time, cash, however most significantly save the sufferers from anxiousness and pointless diagnostic exams.”

AI most cancers diagnostics firm wins life science innovation award

British AI startup Behold.AI has received Finest UK Digital Well being Resolution on the Prix Galien awards.

The agency was awarded for its pink dot® scientific evaluation software program for detecting lung most cancers from X-rays, which is in use at a number of NHS hospital websites as a part of an unbiased validation on affected person knowledge.

Simon Rasalingham, CEO and chairman, Behold.AI, mentioned: “The peer-reviewed proof we’ve constructed up exhibits that if we roll this know-how out nationally we are able to add within the equal of 233 NHS guide radiologists, which is equal to 255,000 hours of guide time per 12 months.”